SCHEMBL29601220

SCHEMBL29601220

C[C@@H]1CCCN1c1cncc(CO)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 2/20 0.41
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
PDE10A Q9Y233 6/20 0.35
EGLN2 Q96KS0 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KHK P50053 2/20 0.34
SYK P43405 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24324615 1.00 SMPD3 (0.41) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL29600540 0.96 MAPT (0.41) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL24324092 0.96 MAPT (0.41) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL20436549 0.79 PDE10A (0.48) SMPD3KDM4EMAPTL3MBTL1PDE10A
SCHEMBL24270217 0.77 PDE10A (0.42) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL24270218 0.77 PDE10A (0.42) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL24324008 0.73 SMPD3 (0.41) SMPD3ADORA2AADORA1KDM4EMAPT
SCHEMBL1326312 0.73 ALDH1A1 (0.44) SMPD3KDM4EMAPTL3MBTL1PIM1
SCHEMBL24324614 0.72 ADORA2A (0.39) SMPD3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL29600599 0.72 ADORA2A (0.39) SMPD3ADORA2AADORA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225765-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed